Career Enhancement Core - CEC
职业提升核心 - CEC
基本信息
- 批准号:10213170
- 负责人:
- 金额:$ 12.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-05-31
- 项目状态:已结题
- 来源:
- 关键词:AreaAsthmaAutoimmunityBasic ScienceBiologicalClinicalClinical ResearchClinical SciencesCollaborationsCommunicable DiseasesCommunitiesData ReportingDevelopmentEducationEducational process of instructingEnvironmentFacultyFoundationsFundingFunding OpportunitiesFutureGenderGoalsGrantGrowthHypersensitivityImmunityImmunologic Deficiency SyndromesImmunologyInflammationInfluenzaInfrastructureLeadershipLearningMalignant NeoplasmsMedicineMentorsMentorshipMethodsPoliciesPositioning AttributePrincipal InvestigatorResearchResearch PersonnelResearch TrainingResourcesScienceScientistSeedsSex DifferencesTrainingTraining ProgramsTranslational ResearchUniversitiesVaccinesWomen&aposs Healthage differencecareerdata disseminationdesigneffectiveness evaluationgender differencehealth differencehealth equityinterestmicrobiomenovelnovel strategiesprofessorprogramsresearch data disseminationsexskillstraining opportunity
项目摘要
SEX AND AGE DIFFERENCES IN IMMUNITY TO INFLUENZA (SADII) CAREER ENHANCEMENT CORE
SUMMARY
The SADII Career Enhancement Core (CEC) will be led by to Dr. Wendy Bennett in collaboration with the
Johns Hopkins Center for Women’s Health, Sex, and Gender Research. The SADII CEC will provide integrated
career enhancement opportunities to clinical, translational, and basic scientists studying sex differences within
the Johns Hopkins University community. This goal will be met through the following specific aims: Aim 1 will
be to provide a broad, interdisciplinary group of established investigators and junior faculty with collaboration,
networking, dissemination, and mentoring opportunities to equip them with new approaches, skills, and
interdisciplinary perspectives in sex and gender differences research; Aim 2 will be to provide pilot grant
funding for early stage investigators (i.e., investigators at the level of Assistant Professor or below, with
emphasis on diversity of candidates) interested in incorporating sex differences into their clinical, translational,
or basic science research in the broad area of immunology (e.g., asthma and allergy, autoimmunity, cancer,
infectious diseases, inflammation, microbiome, vaccines); Aim 3 will be to integrate educational opportunities
focused on teaching skills and methods for incorporating sex as a biological variable and gender
considerations when planning, analyzing, and reporting data, and research dissemination activities into a broad
range of existing training programs (e.g. KL2 and BIRCWH programs); and Aim 4 will be to evaluate the
effectiveness of the SADII CEC in expanding learning opportunities, dissemination of sex and gender research,
mentorship, and funded research. Johns Hopkins has a strong, research-intensive environment, and has
demonstrated commitment to the BIRCWH and other women’s health and sex/gender research and training
opportunities. We anticipate that the SADII CEC will catalyze the expansion of research in the area of
sex/gender differences in biomedical science, and support the growth of diverse investigators and leaders
committed to the consideration of sex as a biologic variable in the design and conduct of their ongoing and
future studies.
性别和年龄差异对流感(SADII)职业增强核心的差异
概括
Sadii职业增强核心(CEC)将与Wendy Bennett博士一起与
约翰·霍普金斯妇女健康,性别和性别研究中心。 SADII CEC将提供集成的
临床,转化和基础科学家研究性别差异的职业增强机会
约翰·霍普金斯大学社区。这个目标将通过以下特定目标实现:目标1将
提供一个广泛的,跨学科的研究人员,由合作的研究人员和初级教师组成
网络,传播和心理机会,使他们拥有新的方法,技能和
性别和性别差异研究的跨学科观点; AIM 2将提供飞行员赠款
早期调查人员的资金(即助理教授或以下的调查员,
强调候选人的多样性)有兴趣将性别差异纳入其临床,翻译,
或免疫学广泛领域的基础科学研究(例如哮喘和过敏,自身免疫,癌症,
传染病,感染,微生物组,疫苗);目标3将是整合教育机会
专注于将性作为生物变量和性别纳入性别的教学技能和方法
在计划,分析和报告数据以及研究传播活动时的考虑
现有培训计划的范围(例如KL2和BIRCWH计划);目标4将是评估
Sadii CEC在扩大学习机会,传播性别和性别研究方面的有效性,
资术和资助研究。约翰·霍普金斯(Johns Hopkins)有一个强大的研究密集环境,并且
表现出对BIRCWH和其他妇女健康,性别/性别研究和培训的承诺
机会。我们预计SADII CEC将促进该领域的研究的扩展
生物医学科学中的性别/性别差异,并支持潜水员研究者和领导者的成长
致力于将性作为生物学变量在其持续和行为中的生物变量
未来的研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Wendy Lynet Bennett其他文献
Wendy Lynet Bennett的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Wendy Lynet Bennett', 18)}}的其他基金
The Effect of Sex Hormones on Cardiometabolic Outcomes in Men and Women with Diabetes: The Look AHEAD (Action for Health in Diabetes) Study
性激素对男性和女性糖尿病患者心脏代谢结果的影响:展望未来(糖尿病健康行动)研究
- 批准号:
10262947 - 财政年份:2020
- 资助金额:
$ 12.94万 - 项目类别:
Healthy for 2/Healthy for U: A Pragmatic Randomized Clinical Trial to Limit Gestational Weight Gain and Prevent Obesity in the Prenatal Care Setting
2 岁健康/U 健康:一项在产前护理环境中限制妊娠体重增加和预防肥胖的实用随机临床试验
- 批准号:
10359707 - 财政年份:2020
- 资助金额:
$ 12.94万 - 项目类别:
The Effect of Sex Hormones on Cardiometabolic Outcomes in Men and Women with Diabetes: The Look AHEAD (Action for Health in Diabetes) Study
性激素对男性和女性糖尿病患者心脏代谢结果的影响:展望未来(糖尿病健康行动)研究
- 批准号:
10474585 - 财政年份:2020
- 资助金额:
$ 12.94万 - 项目类别:
Healthy for 2/Healthy for U: A Pragmatic Randomized Clinical Trial to Limit Gestational Weight Gain and Prevent Obesity in the Prenatal Care Setting
2 岁健康/U 健康:一项在产前护理环境中限制妊娠体重增加和预防肥胖的实用随机临床试验
- 批准号:
10581516 - 财政年份:2020
- 资助金额:
$ 12.94万 - 项目类别:
Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in Pregnancy
降低妊娠期高血压或糖尿病女性的心血管风险
- 批准号:
8130655 - 财政年份:2010
- 资助金额:
$ 12.94万 - 项目类别:
Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in Pregnancy
降低妊娠期高血压或糖尿病女性的心血管风险
- 批准号:
8309124 - 财政年份:2010
- 资助金额:
$ 12.94万 - 项目类别:
Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in Pregnancy
降低妊娠期高血压或糖尿病女性的心血管风险
- 批准号:
8700465 - 财政年份:2010
- 资助金额:
$ 12.94万 - 项目类别:
Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in Pregnancy
降低妊娠期高血压或糖尿病女性的心血管风险
- 批准号:
7771991 - 财政年份:2010
- 资助金额:
$ 12.94万 - 项目类别:
Reducing Cardiovascular Risk in Women with Hypertension or Diabetes in Pregnancy
降低妊娠期高血压或糖尿病女性的心血管风险
- 批准号:
8502542 - 财政年份:2010
- 资助金额:
$ 12.94万 - 项目类别:
相似国自然基金
PFKFB3介导的糖酵解通过诱导气道上皮细胞功能失调加重哮喘气道炎症和气道重塑的机制
- 批准号:82300041
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
NGF通过上调ASIC1a表达激活AMPK/FoxO3a信号通路促进气道上皮细胞自噬诱导支气管哮喘的机制研究
- 批准号:82360008
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
外泌体介导肥大细胞类糜蛋白酶调控哮喘气道平滑肌增殖和机制研究
- 批准号:82370033
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
CD207阳性树突状细胞在过敏性哮喘气道炎症中作用及机制研究
- 批准号:82370035
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Neuropilin-1活化肺2型固有淋巴样细胞促进肺哮喘发生的机制研究
- 批准号:32300727
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Polymer-derived biomaterials for mRNA delivery to induce antigen-specific immune tolerance
用于 mRNA 递送以诱导抗原特异性免疫耐受的聚合物衍生生物材料
- 批准号:
10886168 - 财政年份:2023
- 资助金额:
$ 12.94万 - 项目类别:
Chemotactic Cytokines Gordon Research Conference and Seminar
趋化细胞因子戈登研究会议及研讨会
- 批准号:
10468353 - 财政年份:2022
- 资助金额:
$ 12.94万 - 项目类别:
Microbial Dysbiosis Among Veterans Following Deployment-Related Airborne Exposures
退伍军人在与部署相关的空气暴露后出现微生物失调
- 批准号:
10426050 - 财政年份:2021
- 资助金额:
$ 12.94万 - 项目类别:
Studies of a new checkpoint regulator in controlling lung inflammation
控制肺部炎症的新检查点调节剂的研究
- 批准号:
10229265 - 财政年份:2020
- 资助金额:
$ 12.94万 - 项目类别: